Juan Zhou Selected Research

Gefitinib (Iressa)

4/2018	Sensitivity to chemotherapeutics of NSCLC cells with acquired resistance to EGFR-TKIs is mediated by T790M mutation or epithelial-mesenchymal transition.
1/2015	Randomized study of gefitinib versus pemetrexed as maintenance treatment in patients with advanced glandular non-small cell lung cancer.
1/2014	Sequence-dependent antiproliferative effects of gefitinib and docetaxel on non-small cell lung cancer (NSCLC) cells and the possible mechanism.
8/2013	The role of epithelial-mesenchymal transition and IGF-1R expression in prediction of gefitinib activity as the second-line treatment for advanced nonsmall-cell lung cancer.
6/2008	[Effects of paclitaxel and gefitinib on the proliferation and cell cycle of human lung adenocarcinoma cell SPC-A1.].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Juan Zhou Research Topics

Disease

119	Neoplasms (Cancer) 04/2024 - 08/2002
48	Inflammation (Inflammations) 03/2024 - 11/2007
31	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2023 - 06/2008
28	Breast Neoplasms (Breast Cancer) 01/2023 - 01/2014
22	Neoplasm Metastasis (Metastasis) 10/2023 - 09/2012
21	Sepsis (Septicemia) 12/2022 - 01/2010
18	Infections 04/2024 - 08/2005
18	Ovarian Neoplasms (Ovarian Cancer) 12/2023 - 09/2012
15	Atherosclerosis 12/2021 - 03/2014
13	Pain (Aches) 01/2024 - 01/2014
13	Hepatocellular Carcinoma (Hepatoma) 01/2024 - 08/2006
13	Endotoxemia 01/2021 - 01/2010
12	Lung Neoplasms (Lung Cancer) 01/2024 - 03/2008
12	Cardiovascular Diseases (Cardiovascular Disease) 10/2023 - 12/2013
11	Prostatic Neoplasms (Prostate Cancer) 02/2024 - 01/2013
11	Uterine Cervical Neoplasms (Cancer of the Cervix) 09/2023 - 01/2015
10	Stomach Neoplasms (Stomach Cancer) 04/2024 - 04/2015
10	Acute Coronary Syndrome 01/2024 - 10/2018
10	Fibrosis (Cirrhosis) 08/2023 - 01/2005
9	COVID-19 12/2024 - 01/2020
9	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2024 - 01/2017
9	Hypoxia (Hypoxemia) 11/2023 - 01/2011
9	Adenocarcinoma of Lung 07/2022 - 02/2007
9	Asthma (Bronchial Asthma) 06/2021 - 03/2012
8	Stroke (Strokes) 04/2024 - 01/2016
8	Pneumonia (Pneumonitis) 03/2024 - 07/2017
8	Adenocarcinoma 01/2024 - 01/2017
8	Hypertension (High Blood Pressure) 10/2023 - 11/2015
8	Coronary Artery Disease (Coronary Atherosclerosis) 01/2023 - 08/2016
8	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 03/2014
7	Liver Neoplasms (Liver Cancer) 01/2024 - 04/2012
7	Wounds and Injuries (Trauma) 11/2023 - 08/2019
7	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 11/2023 - 06/2013
7	Carcinoma (Carcinomatosis) 10/2023 - 04/2012
7	Disease Progression 01/2023 - 01/2014
7	Adenoma (Adenomas) 01/2022 - 03/2015
7	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 06/2012
7	Carcinogenesis 07/2020 - 01/2015
7	Peritonitis 01/2020 - 11/2010
6	Hemorrhage 03/2024 - 01/2016
6	Nasopharyngeal Carcinoma 10/2023 - 11/2009
6	Myocardial Infarction 01/2021 - 01/2004
6	Cognitive Dysfunction 01/2020 - 01/2016
5	Edema (Dropsy) 03/2024 - 01/2014
5	Acute Lung Injury 03/2024 - 06/2022
5	Ovarian Epithelial Carcinoma 11/2023 - 05/2013
5	Interstitial Cystitis (Interstitial Cystitis, Chronic) 05/2023 - 01/2019
5	Body Weight (Weight, Body) 01/2023 - 10/2003
5	Schizophrenia (Dementia Praecox) 01/2023 - 06/2012

Drug/Important Bio-Agent (IBA)

36	Biomarkers (Surrogate Marker)IBA 01/2024 - 05/2010
26	Proteins (Proteins, Gene)FDA Link 02/2024 - 01/2009
20	CytokinesIBA 01/2024 - 12/2007
18	Peptides (Polypeptides)IBA 01/2020 - 12/2013
16	Immune Checkpoint InhibitorsIBA 01/2024 - 04/2020
15	LipopolysaccharidesIBA 03/2024 - 11/2007
15	IronIBA 07/2023 - 01/2004
13	DNA (Deoxyribonucleic Acid)IBA 11/2023 - 04/2012
13	MicroRNAs (MicroRNA)IBA 12/2022 - 04/2012
12	Tyrosine Kinase InhibitorsIBA 07/2023 - 01/2014
12	LipidsIBA 01/2023 - 03/2003
11	Long Noncoding RNAIBA 11/2023 - 05/2018
11	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2023 - 07/2010
11	ErbB Receptors (EGF Receptor)IBA 07/2023 - 01/2014
10	EnzymesIBA 05/2022 - 06/2015
10	Messenger RNA (mRNA)IBA 01/2021 - 12/2007
10	Apolipoproteins E (ApoE)IBA 11/2019 - 06/2012
9	CollagenIBA 01/2023 - 04/2011
9	CholesterolIBA 01/2022 - 03/2014
8	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2023 - 10/2011
8	Chelating AgentsIBA 01/2021 - 01/2016
7	Therapeutic UsesIBA 11/2023 - 01/2016
7	3-hydroxypyridin-4-oneIBA 06/2022 - 01/2016
7	Small Interfering RNA (siRNA)IBA 01/2021 - 10/2015
6	CannabinoidsIBA 04/2024 - 01/2019
6	Interleukin-6 (Interleukin 6)IBA 01/2024 - 11/2007
6	SolutionsIBA 11/2023 - 01/2005
6	HydrogelsIBA 11/2023 - 08/2019
6	LigandsIBA 02/2023 - 07/2007
6	Indicators and Reagents (Reagents)IBA 01/2023 - 11/2010
6	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 01/2010
6	ApolipoproteinsIBA 01/2021 - 07/2014
6	Cannabinoid Receptors (Cannabinoid Receptor)IBA 11/2019 - 06/2012
6	Hormones (Hormone)IBA 12/2018 - 01/2015
5	Silicon Dioxide (Silica)FDA LinkGeneric 11/2023 - 08/2018
5	EndotoxinsIBA 10/2023 - 01/2016
5	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 09/2014
5	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 12/2022 - 12/2019
5	MicellesIBA 09/2021 - 01/2016

Therapy/Procedure

63	Therapeutics 04/2024 - 01/2005
25	Drug Therapy (Chemotherapy) 02/2024 - 08/2002
23	Radiotherapy 10/2023 - 01/2014
14	Immunotherapy 01/2024 - 01/2016
11	Stents 01/2020 - 08/2005
10	Mastectomy (Mammectomy) 01/2020 - 01/2014
9	Hysterectomy 09/2018 - 01/2015
8	Lymph Node Excision (Lymph Node Dissection) 09/2023 - 01/2015
8	Percutaneous Coronary Intervention 01/2023 - 10/2015
7	Chemoradiotherapy 01/2024 - 01/2014
5	Transplantation 11/2023 - 01/2016
5	Neoadjuvant Therapy 01/2022 - 10/2015